Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry E Stewart

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Surgical Research|April 12, 2015
Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survivalLauren A Gillory, Jerry E Stewart, Michael L Megison, et al.
Clinical & Experimental Metastasis|December 5, 2012
FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastomaMichael L Megison, Jerry E Stewart, Hugh C Nabers, et al.
Molecular Carcinogenesis|October 16, 2012
Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell linesElizabeth A Beierle, Xiaojie Ma, Jerry E Stewart, et al.
Journal of Pediatric Surgery|April 3, 2024
PIM Kinase Inhibition Sensitizes Neuroblastoma to DoxorubicinJanet R Julson, Colin H Quinn, Nazia Nazam, et al.
The Journal of Biological Chemistry|November 24, 2004
p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brainQiang Ding, J Robert Grammer, Mark A Nelson, et al.
Molecular Carcinogenesis|July 23, 2013
Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastomaJerry E Stewart, Xiaojie Ma, Michael Megison, et al.
Molecular Cancer Research : MCR|January 28, 2014
FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumorsMichael L Megison, Lauren A Gillory, Jerry E Stewart, et al.
Translational Oncology|April 2, 2013
FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In VivoLauren A Gillory, Jerry E Stewart, Michael L Megison, et al.
Cancer Biology & Therapy|March 27, 2007
ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesisJoshua C Anderson, J Robert Grammer, Wenquan Wang, et al.
Translational Oncology|August 29, 2016
Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma CellsAlicia M Waters, Laura L Stafman, Evan F Garner, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Surgical Research|April 12, 2015
Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survivalLauren A Gillory, Jerry E Stewart, Michael L Megison, et al.
Clinical & Experimental Metastasis|December 5, 2012
FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastomaMichael L Megison, Jerry E Stewart, Hugh C Nabers, et al.
Molecular Carcinogenesis|October 16, 2012
Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell linesElizabeth A Beierle, Xiaojie Ma, Jerry E Stewart, et al.
Journal of Pediatric Surgery|April 3, 2024
PIM Kinase Inhibition Sensitizes Neuroblastoma to DoxorubicinJanet R Julson, Colin H Quinn, Nazia Nazam, et al.
The Journal of Biological Chemistry|November 24, 2004
p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brainQiang Ding, J Robert Grammer, Mark A Nelson, et al.
Molecular Carcinogenesis|July 23, 2013
Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastomaJerry E Stewart, Xiaojie Ma, Michael Megison, et al.
Molecular Cancer Research : MCR|January 28, 2014
FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumorsMichael L Megison, Lauren A Gillory, Jerry E Stewart, et al.
Translational Oncology|April 2, 2013
FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In VivoLauren A Gillory, Jerry E Stewart, Michael L Megison, et al.
Cancer Biology & Therapy|March 27, 2007
ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesisJoshua C Anderson, J Robert Grammer, Wenquan Wang, et al.
Translational Oncology|August 29, 2016
Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma CellsAlicia M Waters, Laura L Stafman, Evan F Garner, et al.
Pageof 6